Protalix is a publicly traded biotechnology company
(NYSE Amex: PLX),
that is producing recombinant therapeutic proteins through the ProCellEx™ plant cell system.
HOME PAGE
ABOUT US
Corporate Profile
Market Needs
Protalix Advantage
Management Team
Scientific Advisory Board
Press Room
Careers
TECHNOLOGY
ProCellEx Overview
Platform Technology
Protein Production
PRODUCT DEVELOPMENT
taliglucerase alfa (UPLYSO)
Pipeline Products
PARTNERSHIPS
INVESTORS
Corporate Strategy
Board of Directors
Management Team
Stock Information
Corporate Governance
Filings
Press Releases
FAQs
EVENT CALENDER
CONTACT US
Patients
Investor Relations
EVENT CALENDER
EVENT CALENDER
Date
Event
Conference Location
February 10-12, 2010
6th Annual Lysosomal Disease Network: WORLD Symposium
Miami, Florida
April 8, 2010
Protalix BioTherapeutics Inc. at BioCentury and Thomson Reuters Future Leaders In The Biotech Industry Conference
May 3-6 , 2010
Bio Conference 2010- Protalix’ presentation, May 6 at 1:15 pm, Room B
Chicago
May 16, 2010
Oppenheimer 11th Annual Israeli Conference
Tel Aviv, Israel
May 26-27, 2010
Citi 2010 Global Health Care Conference
New York
June 8-11, 2010
Jefferies: Global Life Sciences Conference
New York
June 14-16, 2010
ILSI Biomed 2010 Conference
Tel Aviv, Israel
June 30 – July 3, 2010
9
th
International EWGGD Meeting
Cologne , Germany
August 10-12, 2010
Canaccord Adams 30th Annual Global Growth Conference
Boston, Massachusetts
September 20 - 22, 2010
UBS Global Life Sciences Conference
New York
© 2007 Protalix Biotherapeutics. All Rights Reserved.